Cardiovascular Drug Reviews
Published by Neva Press, Inc.
ISSN : 0897-5957 eISSN : 1527-3466
Abbreviation : Cardiovasc. Drug Rev.
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Role of Poly(ADPâ€ribose) polymerase 1 (PARPâ€1) in Cardiovascular Diseases: The Therapeutic Potential of PARP Inhibitors
Citation: 268
Authors: Pál, Csaba
-
Olprinone: A Phosphodiesterase III Inhibitor with Positive Inotropic and Vasodilator Effects
Citation: 260
Authors: Katsufumi, Takashi, Kazushi, Hitoshi
-
Cardiovascular Actions of Berberine
Citation: 218
Authors: Chiâ€Wai, Xiaoâ€Qiang, Zhenâ€Yu, Wingâ€Hung, Yu
-
Prasugrel: A Novel Thienopyridine Antiplatelet Agent. A Review of Preclinical and Clinical Studies and the Mechanistic Basis for Its Distinct Antiplatelet Profile
Citation: 193
Authors: Joseph A., Kenneth J., Hideo, Lars
-
A Review on Telmisartan: A Novel, Longâ€Acting Angiotensin IIâ€Receptor Antagonist
Citation: 188
Authors: Wolfgang, Michael, Jacobus C. A., Joachim, Ulrich, Thomas, Jochen, Horst, Kandace, Joan, Volker, Norbert H.
-
Therapeutic Use of Citrulline in Cardiovascular Disease
Citation: 182
Authors: Maritza J., Daniel H., Ruth B., R. William